Inspired by traditional structure-based algorithms in computer-aided drug design (CADD), we propose the concept of "structure-based Artificial Intelligence Drug Design" .
Relying on cutting-edge technologies such as DNA Encoded Libraries (DEL) screening, we have developed unique advantages in high-throughput drug screening.
Enzyme Coupler Induced Pathway Silencing(ECLIPSE) technology is the exclusive scientific achievement of Dr. Hu Qi, one of the co-founders, addressing the issue of resistance mutations in anti-tumor drug molecules.